COVID-19 interstitial pneumonia: monitoring the clinical course in survivors.

Raghu, Ganesh; Wilson, Kevin C

Raghu, Ganesh; Wilson, Kevin C.

Raghu G; Division of Pulmonary, Sleep & Critical Care Medicine, Director, Center for Interstitial Lung Disease, Department of Medicine, and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA. Electronic address: graghu@uw.edu.
Wilson KC; Division of Allergy, Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Lancet Respir Med ; 8(9): 839-842, 2020 09.

Article in English | MEDLINE | ID: covidwho-692512

Subject(s)

Betacoronavirus; Coronavirus Infections/complications; Long Term Adverse Effects/virology; Lung Diseases, Interstitial/virology; Pneumonia, Viral/complications; COVID-19; Coronavirus Infections/virology; Female; Humans; Lung/virology; Male; Pandemics; Pneumonia, Viral/virology; SARS-CoV-2; Survivors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Lung Diseases, Interstitial / Coronavirus Infections / Long Term Adverse Effects / Betacoronavirus Type of study: Prognostic study Topics: Long Covid Limits: Female / Humans / Male Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google